American multinational healthcare product company Baxter International on Tuesday agreed to pay $18 million as part of a settlement with the Securities and Exchange Commission (SEC) for accounting violations related to the recording of foreign currency transactions.
Baxter neither admitted nor denied the SEC’s findings. The company was found to have violated the negligence-based anti-fraud, reporting, books and records, and internal accounting controls provisions of the federal securities laws.
